CARsgen Therapeutics Holdings Ltd. (HK:2171) has released an update.
At CARsgen Therapeutics Holdings Ltd.’s recent Annual General Meeting, shareholders passed all resolutions with overwhelming support, including the re-election of board members, the re-appointment of Ernst & Young as auditors, and the approval of proposed amendments to the company’s articles of association. Notably, resolutions to authorize share issuance and repurchase mandates were also approved, demonstrating strong investor confidence in the company’s governance and strategic direction.
For further insights into HK:2171 stock, check out TipRanks’ Stock Analysis page.